| Company/Division name | GlaxoSmithKline |
| Parent company | GlaxoSmithKline |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 150 |
| Year reshoring announced: | 2019 |
| Capital investment ($): | 16.7 |
| Country(ies) from which reshored: | United Kingdom |
| City reshored to: | Richmond |
| State(s) reshored to: | VA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | research & development for pharmaceuticals |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Government Incentives, Skilled workforce availability/training, Under-utilized capacity, Other, joint venture |
| Government Incentive dollar amount: | $675,000 |
